High altitudes and partial pressure of arterial oxygen in patients with chronic obstructive pulmonary disease - A systematic review and meta-analysis.

Arterial blood gas COPD High altitude medicine

Journal

Pulmonology
ISSN: 2531-0437
Titre abrégé: Pulmonology
Pays: Spain
ID NLM: 101723786

Informations de publication

Date de publication:
18 Jul 2024
Historique:
received: 27 12 2023
revised: 13 05 2024
accepted: 04 06 2024
medline: 20 7 2024
pubmed: 20 7 2024
entrez: 19 7 2024
Statut: aheadofprint

Résumé

Prior study in healthy subjects has shown a reduction of partial pressure of arterial oxygen (PaO To provide an effect size estimate for the decline in PaO A systematic search of PubMed and Embase was performed from inception to May 30, 2023. Peer-reviewed and prospective studies in patients with COPD staying at altitudes >1500 m providing arterial blood gases within the first 3 days at the target altitude. Aggregate data (AD) on study characteristics were extracted, and individual patient data (IPD) were requested. Estimates were pooled using random-effects meta-analysis. Relative risk estimates and 95 % confidence intervals for the association between PaO Thirteen studies were included in the AD analysis, of which 6 studies (222 patients, 45.2 % female) provided IPD, thus were included in the quantitative analysis. The estimated effect size of PaO This meta-analysis, providing altitude-related decrease in PaO

Identifiants

pubmed: 39030093
pii: S2531-0437(24)00095-3
doi: 10.1016/j.pulmoe.2024.06.002
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest The authors declare no conflict of interest concerning this work.

Auteurs

A Sevik (A)

Department of Respiratory Medicine, University Hospital Zurich, Zurich, Switzerland.

T Gaisl (T)

Department of Respiratory Medicine, University Hospital Zurich, Zurich, Switzerland; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA.

A Forrer (A)

Department of Respiratory Medicine, University Hospital Zurich, Zurich, Switzerland.

L Graf (L)

Department of Respiratory Medicine, University Hospital Zurich, Zurich, Switzerland.

S Ulrich (S)

Department of Respiratory Medicine, University Hospital Zurich, Zurich, Switzerland; Swiss-Kyrgyz High-Altitude Medicine and Research Initiative, Zurich, Bishkek, Switzerland, Kyrgyz Republic.

K E Bloch (KE)

Department of Respiratory Medicine, University Hospital Zurich, Zurich, Switzerland; Swiss-Kyrgyz High-Altitude Medicine and Research Initiative, Zurich, Bishkek, Switzerland, Kyrgyz Republic.

M Lichtblau (M)

Department of Respiratory Medicine, University Hospital Zurich, Zurich, Switzerland; Swiss-Kyrgyz High-Altitude Medicine and Research Initiative, Zurich, Bishkek, Switzerland, Kyrgyz Republic.

M Furian (M)

Department of Respiratory Medicine, University Hospital Zurich, Zurich, Switzerland; Swiss-Kyrgyz High-Altitude Medicine and Research Initiative, Zurich, Bishkek, Switzerland, Kyrgyz Republic; Research Department, Swiss University for Traditional Chinese Medicine, Bad Zurzach, Switzerland. Electronic address: michael.furian@usz.ch.

Classifications MeSH